Background. Numerous studies have found that cost strongly influences patients' decision making. The objective of this study was to explore the impact of varying cost formats on patients' preferences. Methods. Mechanical Turk workers completed a choice-based conjoint (CBC) survey. The CBC survey was designed to examine stated preferences for the use of second-line agents to treat diabetes across 5 attributes: route of administration, efficacy, risk of low blood sugar, frequency of checking blood sugar levels, and cost. We developed 7 versions of the CBC survey that were identical except for the cost attribute. We described cost in terms of: Affordability, Monthly Co-pay, Dollar Sign Rating, How Expensive, or How Cheap compared with other medications, Working Hours Equivalent (per mo) and Percent of Monthly Income. The resulting part-worth utilities were used to calculate the relative importance of cost and to estimate treatment preferences for exenatide, a sulfonylurea, and insulin. Results. The relative impact of cost varied significantly across the 7 formats. Cost had the greatest influence on participants' decisions when framed in terms of Affordability [mean (SD) relative importance, 37.3 (0.9)] and the lowest influence when framed in terms of How Cheap (compared with other drugs) [12.1 (0.9)]. A sulfonylurea was strongly preferred across 4 of the 7 formats. Preference for insulin, the most effective, albeit riskiest, option was low across all cost formats. Conclusions. The format used to describe cost affects how the attribute impacts patients' preferences. Individuals are most costsensitive when cost is framed in terms of affordability and least cost-sensitive when cost is described in terms of how cheap the medication is compared with others.
N umerous studies have found that out-of-pocket costs strongly influence patients' decision making. Goldman and others (2007) 1 and Cole and others (2006) 2 found that a 10% increase in cost sharing is associated with a 1% to 6% reduction in patients' prescription drug spending and decreased medication adherence. Shapiro and others (1986) 3 showed that patients participating in a cost sharing program were less likely to seek medical care for minor symptoms and to be hospitalized for more serious symptoms as compared with those receiving free care. Patients also consider cost when comparing available treatment options. Tseng and others (2010) 4 found that, of 5,085 diabetic patients across 10 health plans, at least two-thirds were willing to consider lower cost medications with less efficacy, more frequent dosing, or a slightly higher chance of side effects. Despite the significant impact of cost on patient decision making, medication expense is rarely discussed during medical encounters 5, 6 and, physicians often feel uncomfortable discussing costs with their patients. [6] [7] [8] [9] Compounding the problem is that specific costs vary widely and are often difficult to access. 10 Healthcare providers and researchers' increasing awareness of cost as a possible treatment harm emphasizes the need to recognize cost as a specific attribute that should be weighed in parallel with other treatment characteristics. [11] [12] [13] This stance is compatible with recent studies demonstrating that most patients want to know about out-of-pocket costs and feel comfortable discussing cost with their physicians. 14 However, little is known about how best to describe cost and whether different cost formats influence patients' preferences.
In a recent systematic review of decision aids, Blumenthal-Barby and others (2015) 15 found that cost-related data were mentioned in 56% of the studies analyzed. Cost descriptions varied from the mere mention of cost to inclusion of specific prices. In this study, we sought to build on this work by examining the impact of specific cost formats on individuals' stated preferences. Formats were chosen to represent a spectrum of commonly used descriptions that could be described across specific levels. We included formats that presented cost in terms of absolute numbers (Monthly Co-Pay, Working Hours Equivalent, and Percent of Monthly Income), familiar symbols (Dollar Sign Rating), and relative verbal phrases (How Expensive or Cheap as compared with other medications and degree of Affordability). In addition to these main differences, we expected that these particular formats would show differences in patients' interpretation of the gist and their affective reactions as well as the evaluability of each format; all of these factors strongly influence preferences. [16] [17] [18] We used an online choice-based conjoint (CBC) survey to quantify how presentation of cost information influenced the importance that individuals attach to out-of-pocket costs and their preferences for specific treatment options. CBC is a widely used stated-preference method that yields valuable insight across many health-related scenarios. 19 Participants' preferences are measured by their choices on a set of hypothetical options described by a predefined list of attributes. Responses generate a set of part-worth utilities that can be used to calculate the relative importance of each attribute and to predict preferences for specified treatment options.
The survey was designed to elicit preferences for a range of medications used to treat diabetes mellitus. Diabetes was chosen because 1) this disease is a major public health issue in the US, resulting in substantial morbidity and mortality; 2) patients incur substantial costs to care for this chronic disorder; 3) costs vary substantially across treatment; and 4) the disease is familiar to the general public. 20, 21 We developed 7 versions of the survey that were identical with the exception of the format used to describe the out-of-pocket cost. Given the known influence of format on patients' choices, we hypothesized that the relative importance of cost and stated treatment preferences would vary by format.
METHODS

Subjects
We recruited 1,500 participants from Amazon's Mechanical Turk (MTurk). MTurk is an online labor market. Its population is more demographically diverse than standard internet samples. 22 Participants on MTurk are internally motivated and produce psychometrically sound data. 23, 24 Although not representative of a patient population, MTurk is a valuable approach to examine the impact of manipulating factors using experimental designs. We included subjects currently living in the US who were at least 20 y old. Participants were paid $1.00.
Survey
We developed an educational overview of diabetic medication management, and an explanation of each of the attributes and levels included in the survey using Qualtrics (see Appendix). At the end of the educational component, we provided subjects with a link to access 1 of the 7 versions of the CBC survey using random assignment. Randomization was conducted by Qualtrics.
The CBC survey was designed, conducted and analyzed with Sawtooth Software, Choice Based Conjoint, Version 8.4.3 (Orem, UT). The survey included 5 attributes (see Table 1 ). All attributes were rated across 3 levels, with the exception of the route of administration, which included only 2 levels. The attributes were selected based on the content of a previously published decision aid. 25 We developed 7 versions of the CBC survey. All 7 versions were identical with the exception of the cost attribute. We described cost in terms of: Affordability, Monthly Co-pay, Dollar Sign Rating, How Expensive (compared to other medications), How Cheap (compared to other medications), Working Hours Equivalent (per mo) and Percent of Monthly Income ( Table 1 ). The level for Affordability, Monthly Co-pay, Dollar Sign Rating, How Expensive, and How Cheap were defined based on the review of decision aids by Blumenthal-Barby and others (2015). 15 The levels for Working Hours Equivalent and Percent of Monthly Income were defined based on WHO reports on the affordability of medications and the median net compensation US per capita. 26, 27 Participants were asked to respond to 12 CBC choice sets, each including 3 unlabeled options. A ''None'' option was not included. An example of a choice set is provided Figure 1 . We used the software's complete enumeration strategy to construct the 12 choice sets. This approach ensures that 1) each level is shown as few times as possible in a single task; 2) each level is shown approximately an equal number of times across the choice tasks; and 3) the level of one characteristic is chosen independently of the levels of other characteristics, so that each characteristic level's effect can be reliably estimated. The program was set to generate a design for 300 versions of the CBC survey in each group. The standard error for each level was 0.02 and the efficiencies reported were all 1.000. In addition to the 12 random CBC choice sets, 2 fixed tasks with a clear advantageous option were set to check participants' attention. After the respondents had completed the CBC survey, we collected data on participants' age, gender, income, education level, health insurance, history of regular use of prescription medications, and whether or not they had diabetes.
Statistical Analysis
For each respondent, part-worth utilities (zerocentered values) were calculated for each level of each attribute using Hierarchical Bayes (HB) . HB modeling has the advantage that it can better incorporate heterogeneity between respondents' choices. 28 In HB modeling, the sample averages (prior information) are used to update the individual utilities in a number of iterations until the sample averages stop changing between iterations. After this convergence, the cycle is run several thousand more times and the estimates of each iteration are saved and averaged. We rescaled the utilities on a scale of 0 to 1, using the highest (i.e., least preferred) cost level as the reference (0). We calculated the percentage of importance that respondents assigned to each attribute by dividing the range of part-worth utilities for each attribute by the sum of the ranges and multiplying by 100. We used Sawtooth Software Market Research Tools (SMRT) to estimate preferences for 3 potential second-line medications for type 2 diabetes: 29 insulin, sulfonylureas, and exenatide. For this simulation, sulfonylureas were assigned the lowest cost level, insulin the middle level, and exenatide the most expensive level. The levels assigned for all attributes to each of these treatment options are provided in Table 1 . We also used SMRT to illustrate participants' price sensitivity for preferring insulin over exenatide as the cost for exenatide was fixed at $350 per mo, and out-of-pocket cost of insulin was decreased from $350 to $15 per mo using Sawtooth's linear interpolating function.
We excluded subjects who did not answer either of the attention-check questions correctly: 48 participants failed to correctly answer both attentioncheck questions and 122 failed to answer one correctly. We subsequently excluded an additional 77 participants who completed the survey in less than 3.5 min (the 5 th percentile). The average (SD) time to complete the survey was 7.2 (3.5) min.
Preference data were imported into SAS Version 9.3 (Cary, NC) and merged with the respondents' characteristics. We compared participants' characteristics across the 7 versions, using the chi-square test for categorical data and ANOVA for continuous data. We compared the relative importance of the cost attribute across the 7 formats using ANOVA and Tukey's method to correct for multiple comparisons. We examined whether subjects' characteristics [age, gender, annual income (\$25,000 v. $25,000), college graduate (yes v. no), covered by health insurance (yes v. no), regular use of prescription medications (yes v. no), diabetes (yes v. no)] were associated with the relative importance of cost for each format using separate multiple linear regression models. The study was approved by the Human Investigation Committee at our institution.
RESULTS
Participants
Eligible participants (n = 1,163) were included in the final analyses. Participants' age ranged from 18 y to 73 y, with a mean of 35.3 y (SD, 11.5 y). Most participants had finished high school (99.5%), 37.6% earned less than $25,000 per y, and 34.2% took prescription medications regularly. Characteristics were similar across the 7 versions of the CBC survey ( Table 2 ). Cost Utilities and Relative Importance Figure 2 plots the rescaled utilities for each level of cost across the 7 formats. Lowering the cost from the high to medium level had a larger impact than lowering the cost from the medium to lowest level for all formats. This difference was most evident for the Affordability and Percent of Monthly Income formats. Increasing the cost from the lowest to the medium level had the greatest impact in the Monthly Co-pay and Percent of Monthly Income formats.
The relative importance of cost differed significantly across the 7 cost formats (Table 3, Figure 3 ). Cost had the greatest influence on participants' decisions when framed in terms of degree of Affordability, and the relative importance of this type of cost was significantly higher than those in the remaining 6 categories. In contrast, cost had the least influence on participants' decisions when framed as How Cheap. Cost was the most influential of the 5 attributes when framed using the formats of Affordability, Monthly Co-pay or Percentage of Monthly Income.
We found no statistically significant associations between the subjects' characteristics and the relative importance of cost across the 7 formats, with the following exceptions: increasing age was associated with a greater importance of cost when described in terms of Affordability (t = 2.69, P = 0.008); the current use of prescription medication was associated with a greater importance of cost when described in terms of Monthly Co-pay (t = 2.96, P = 0.004); higher income was associated with a lower importance of cost when described using the Dollar Sign Rating format ( t = 23.35, P = 0.001); and a higher education level was associated with a lower importance of cost when described using the How Cheap format (t = -2.64, P = 0.009).
Treatment Preferences
Predicted preferences for insulin, exenatide, and sulfonylureas are described in Figure 4 . A sulfonylurea is strongly preferred across 4 of the 7 cost formats. Exenatide is strongly preferred when cost is described using the How Cheap format. In this format, the risk of low blood sugar is the most important attribute (Table 3) , and this risk is substantially lower with exenatide than with a sulfonylurea. A similar pattern is seen with the How Expensive format. The preference for insulin-the most effective, albeit riskiest, option-is low across all cost formats. Figure 5 reveals the estimated preferences for insulin over exenatide (held fixed at $350 per mo) as the out-of-pocket costs for insulin were decreased from $350 to $15 per mo. When described in terms of Percent of Monthly Income or Monthly Co-pay, the preference for insulin supersedes that of exenatide once the cost of insulin is lower than $60 per mo. When described in terms of Working Hours Equivalent, insulin is never preferred over exenatide, even at the lowest co-payments.
DISCUSSION
In this study, we explored whether and how varying the cost presentation format influences individuals' stated preferences. Our results show that the relative importance of cost and treatment preference are sensitive to the manner in which cost is described. We found that cost had the largest impact when described in terms of Affordability and the lowest impact when described by How Cheap the medication is compared with other options.
The formats studied differed in several respects. Affordability may have had the largest impact on subjects' choices because the lowest level ''Hard to afford'' likely evoked a greater negative affective reaction than the other formats. Interestingly, describing the medication using the verbal phrase, ''Much more expensive compared to others'', had a much lower impact, perhaps because ''Hard to afford'' invoked uniformly negative affective reactions regardless of personal income, whereas ''Much more expensive'' invoked more variable responses depending on one's finances and experience purchasing ''expensive'' items. In addition, some may have interpreted more expensive to reflect higher quality or potency. 30, 31 According to Fuzzy-trace theory, people generally rely on gist versus verbatim representations to make decisions. 16, 17 It follows that the differences observed may also have been caused by differences in the gist extracted from each format. For example, Percent of Monthly Income and Working Hours Equivalent had very different impacts on subjects' preferences despite being monetarily equivalent. Fifteen percent may seem larger than 3 days because, when being compared, subjects may have focused on the numerical values rather than on the unit of measurement. In addition, subjects may have had a more negative reaction to Percent of Monthly Income than Working Hours Equivalent, because the former term may be more closely associated with scenarios describing a loss of income (e.g., deductions for social security). This explanation would also be in keeping with prospect theory's emphasis on the influence of loss aversion. 32, 33 The observed variability in subjects' responses may also be in part explained by differences in evaluability. Hsee 18 suggested that attributes that are easier to evaluate have a larger impact on choice. Of the 3 formats described using numerical values, Working Hours Equivalent had the smallest impact on preferences, perhaps because it is relatively harder to calculate and thus less evaluable than Monthy Co-pay and Percent of Monthly Income. Similarly, this hypothesis may also explain why Affordability, a concept familiar and relevant to all and therefore likely more evaluable than the other formats, had the greatest impact on preferences. The importance of evaluability is also supported by the finding that subjects currently taking prescription medications, and thus familiar with monthly co-payments, were more impacted by the format Monthy Co-pay compared with their counterparts.
The differences in the impact of cost translated into differences in preferred treatment options. Sulfonylureas, the least expensive option, was preferred across 4 of the 7 formats where cost had the largest impact even though this treatment is less effective and more likely to cause hypoglycemia than insulin. Exenatide, the most expensive option, was preferred in the remaining 3 formats, most notably when using the How Cheap format. This finding has potentially important clinical implications, as varying terminology may influence patients in a manner that could alter their treatment decisions. Thus, future research should determine if alternative formats of information delivery have an impact on patients' decisions in clinical settings. This study may also have implications for other health decisions, such as patients' choices of health plans or healthcare providers. 34, 35 To the best of our knowledge, this is the first study to explore the impact of varying cost formats on subjects' preferences. We used a randomized, between-subjects experimental design, which enabled us to isolate the effect of the manipulated variable. In addition, CBC enabled us to quantify the relative importance of cost as an attribute, to compare differences in subjects' reactions to increasing the cost from a low to medium level versus a medium to high level, and to estimate preferences for competing treatment options. There are also several limitations of the study. First, as with other studies using simulated scenarios, stated preferences may not reflect the actual decision-making process in a clinical setting, which would involve many other important issues. Although we discuss the role of affect, we did not explicitly measure affective reactions to the different formats presented. Furthermore, although we designed the surveys based on a pre-established decision-aid for the escalation of diabetic care, patients may consider other attributes when making treatment decisions. In addition, the study was conducted online using MTurk workers, and further research is required to examine the effects of varying cost presentation in patients. Lastly, future studies should test the possible explanations described in the discussion and explore additional reasons underlying the variability observed in this study.
In summary, we found that the format by which cost is described has a significant impact on respondents' choices. Participants in this study were most cost-sensitive when considering the affordability of a medication, and influenced by cost least when considering how cheap a medication was as compared with other options. When using actual numerical values to describe co-payments, Working Hours Equivalent had less impact than either Monthly Co-pay or the Percent of Monthly Income. Clinicians and researchers should be aware of the potential impact of variable presentation formats on preferences. These results support the need to evaluate the impact of the presentation of cost on preferences in a clinical context.
